InMed Pharmaceuticals (INM) Inventory Average (2022 - 2025)

InMed Pharmaceuticals' Inventory Average history runs 4 years deep, the most recent figure standing at $919352.5 for Q4 2025.

• On a quarterly basis, Inventory Average fell 20.86% year-over-year to $919352.5 in Q4 2025; TTM through Dec 2025 was $919352.5, a 20.86% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 22.9% from the prior year.
• Inventory Average fell to $919352.5 in Q4 2025 per INM's latest filing, from $925990.0 in the prior quarter.
• Across five years, Inventory Average topped out at $2.1 million in Q3 2022 and bottomed at $887571.5 in Q2 2025.
• The 4-year median for Inventory Average is $1.2 million (2022), against an average of $1.3 million.
• Across the five-year window, Inventory Average slumped 44.64% in 2023 and grew 23.72% in 2024, its largest moves.
• Year by year, Inventory Average stood at $1.7 million in 2022, then slumped by 44.64% to $938968.0 in 2023, then advanced by 23.72% to $1.2 million in 2024, then fell by 20.86% to $919352.5 in 2025.
• Per Business Quant, the three latest INM Inventory Average figures stand at $919352.5 (Q4 2025), $925990.0 (Q3 2025), and $887571.5 (Q2 2025).